Hemodynamic and Oxygen Transport Effects of Pentastarch in Burn Resuscitation
- 28 February 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 209 (3) , 341-345
- https://doi.org/10.1097/00000658-198903000-00015
Abstract
If nonprotein colloid plasma expanders could be demonstrated to be safe and efficacious in burn resuscitation, a significant cost benefit would result. This study was a randomized cross-over comparison of 500 ml of 5% albumin and 500 ml of 10% pentastarch, a new hydroxyethyl starch, in acute burn resuscitation. Pentastarch was an effective plasma expander, resulting in increases of preload, cardiac output, oxygen delivery, and oxygen consumption; the hemodynamic effects of pentastarch infusion were equal or superior to those of albumin. Both albumin and pentastarch infusions resulted in increased bleeding and clotting times; these effects were most likely dilutional Pentastarch is a promising plasma substitute for burn resuscitation; the effects of a 500 ml infusion are equal or superior to those of albumin. Further study is necessary to assess the safety of larger infusion volumes.This publication has 9 references indexed in Scilit:
- The Effects of Burn Injury and Fluid Resuscitation on Cardiac Function in vitroPublished by Wolters Kluwer Health ,1986
- Blood and plasma substitutes--plasma expansion and oxygen transport properties.1985
- Effect of Hydroxyethyl Starch and Dextran on Plasma Volume and Blood Hemostasis and CoagulationThe Journal of Clinical Pharmacology, 1984
- EFFECT OF NONPROTEIN COLLOID ON POSTBURN EDEMA FORMATION IN SOFT-TISSUES AND LUNG1984
- Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patientsCritical Care Medicine, 1983
- Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutionsCritical Care Medicine, 1982
- Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patientsCritical Care Medicine, 1980
- Hydroxyethyl starch.1978
- Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.1967